SHARE-BASED COMPENSATION

6 Months Ended

Jun. 30, 2021

Share-based Payment Arrangement [Abstract]

We maintain an equity incentive plan, the 2020 Equity Incentive Plan, or the 2020 Plan, for the issuance and grant of equity awards (restricted stock, restricted stock units, or RSUs, and incentive and nonqualified stock options) to our officers, directors, employees and certain advisors. As of June 30, 2021, we had 24.7 million common shares authorized and available for issuance under the 2020 Plan.

The following table displays share-based compensation expense recorded in the condensed consolidated statements of operations and comprehensive loss:


	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
	(dollars in millions)
Share-based compensation expense:
Loss and loss adjustment expenses	$	0.5	$	—	$	0.6	$	0.5
Sales and marketing	0.2		—		0.2		1.0
Other insurance expense	0.4		—		0.5		0.9
Technology and development	1.5		0.2		1.8		5.3
General and administrative	2.3		0.3		4.1		18.5
Total share-based compensation expense	$	4.9	$	0.5	$	7.2	$	26.2

The following table provides total share-based compensation expense by type of award:


	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
	(dollars in millions)
Share-based compensation expense:
Restricted stock unit expense	$	4.2	$	—	$	4.8	$	—
Stock option expense	0.7		0.5		2.4		26.2
Total share-based compensation expense	$	4.9	$	0.5	$	7.2	$	26.2

In March 2020, a current investor completed a tender offer for vested common stock from shareholders, many of whom were employees or members of the Board of Directors. To encourage participation, the tender offer was made at a price in excess of the fair value of our common stock. As a result, we recognized $25.1 million of share-based compensation expense during the six months ended June 30, 2020.

As of June 30, 2021, there was $7.4 million and $66.1 million of unrecognized compensation cost related to nonvested stock options and restricted stock units, respectively. The remaining costs are expected to be recognized over a period of approximately six and four years, respectively.

Restricted Stock Units

A summary of RSU activity for the six months ended June 30, 2021 is as follows:


	Six Months Ended June 30, 2021
Restricted Stock Units	Number of Shares	Weighted-Average Grant Date Fair Value per Share		Aggregate Intrinsic Value
	(in millions, except per share amounts)
Nonvested at January 1, 2021	0.4	$	18.41	$	6.2
Granted	5.8	11.55
Vested	—	16.88		0.4
Forfeited, expired or canceled	(0.2)	12.34
Nonvested at June 30, 2021	6.0	$	11.96	$	64.6

Stock Options

A summary of option activity for the six months ended June 30, 2021 is as follows:


	Six Months Ended June 30, 2021
Options	Number of Shares	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value
	(in millions, except exercise price and term amounts)
Outstanding and exercisable at January 1, 2021	10.4	$	2.39	7.75	$	137.7
Granted	—	10.82
Exercised	(2.3)	1.83			23.3
Forfeited, expired or canceled	(0.7)	4.62
Outstanding and exercisable at June 30, 2021	7.4	$	2.44	7.22	$	61.8